A recent analyst update has classified $NOK with an ‘Overweight’ rating, marking a positive outlook for the stock. This rating was issued by JP Morgan on October 24, 2025.
Analyst Ratings Overview for $NOK
In the past few months, Wall Street analysts have closely monitored $NOK. Notably, only one firm has recommended buying the stock, while none have suggested selling it. Here is the latest analyst rating:
- JP Morgan: ‘Overweight’ on October 24, 2025
Congressional Trading Activity
Members of Congress have engaged in trading $NOK stock twice over the last six months. The trades included equal parts purchases and sales. This indicates a measured interest in the stock among lawmakers.
Institutional Investor Movements
Institutional activity around $NOK has been notable. In the most recent quarter, 236 institutional investors increased their stakes, while 207 reduced theirs. Below are some significant changes in holdings:
| Investor | Shares Added/Removed | Percentage Change | Estimated Value |
|---|---|---|---|
| POINT72 Asset Management, L.P. | +19,442,640 | +1563.5% | $100,712,875 |
| FMR LLC | +12,190,591 | +15.5% | $63,147,261 |
| Pzena Investment Management LLC | 11,799,730 | 14.7% | $61,122,601 |
| UBS Group AG | 7,607,688 | 45.5% | $39,407,823 |
| Goldman Sachs Group Inc. | 6,133,505 | 48.9% | $31,771,555 |
| Balyasny Asset Management L.P. | 5,840,010 | 98.0% | $30,251,251 |
| Optiver Holding B.V. | 4,978,498 | 100.0% | $25,788,619 |
This overview of $NOK’s current performance reflects significant interest and dynamic activity among both analysts and investors. As the situation evolves, tracking these developments will be crucial for potential investors.